BREAKING: Washington Doctors SUCCESSFULLY Treat Coronavirus Patient with Experimental Anti-viral Medication — “Significantly” Improved in Hours (VIDEO)

The first person in the US to catch the coronavirus was successfully treated in Washington state and returned home late last week.

Dr. George Diaz, a section chief for infectious diseases at Providence Regional Medical Center Everett joined Arthel Neville on FOX News on Sunday morning to discuss the successful treatment of the center’s coronavirus patient.

Dr. George Diaz: About a week into his course he got worse developed pneumonia. At that point given the reports we had gotten out of China… At that point we elected to give him… the experimental Remdesivir, antiviral medication. And within 24 hours he improved significantly. This was quite encouraging and he improved and thereafter remained without fever and felt much better. Over the next few days he improved to where we thought he could be discharged at home under the care of the local health district.

Arthel Neville: And you said you used, I believe an experimental anti-viral medication, that you gave this patient. Can you apply this treatment to ALL people infected with the coronavirus or does it depend on the stage of their infection?

Dr. George Diaz: Yes, at this point the CDC has been working with the authorities in China and have recently opened a large clinical trial of Chinese patients looking at those with severe disease as well as those with mild to moderate disease. We are very much looking forward to the trials.

Via FOX News:

Photo of author
Jim Hoft is the founder and editor of The Gateway Pundit, one of the top conservative news outlets in America. Jim was awarded the Reed Irvine Accuracy in Media Award in 2013 and is the proud recipient of the Breitbart Award for Excellence in Online Journalism from the Americans for Prosperity Foundation in May 2016. In 2023, The Gateway Pundit received the Most Trusted Print Media Award at the American Liberty Awards.

You can email Jim Hoft here, and read more of Jim Hoft's articles here.

 

Thanks for sharing!